Immix Biopharma, Inc. reports

Location
11400 West Olympic Blvd., Suite 200, Los Angeles, California
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
8/1/2024, 01:31 AM
Form type Sec Links Description Filing date Reporting date
8-K Report | Data Jul 26, 2024 Jul 25, 2024
8-K Report | Data Jul 22, 2024 Jul 17, 2024
8-K Report | Data Jun 14, 2024 Jun 11, 2024
8-K Report | Data May 20, 2024 May 20, 2024
10-Q Report | Data May 9, 2024 Mar 31, 2024
10-K Report | Data Mar 29, 2024 Dec 31, 2023
SC 13G Report Feb 7, 2024
8-K Report | Data Feb 6, 2024 Feb 6, 2024
8-K Report | Data Feb 5, 2024 Feb 5, 2024
10-Q Report | Data Nov 13, 2023 Sep 30, 2023
SC 13D Report GKCC SCHEDULE 13D Aug 30, 2023
8-K Report | Data Aug 22, 2023 Aug 22, 2023
10-Q Report | Data Aug 11, 2023 Jun 30, 2023
8-K Report | Data Jul 14, 2023 Jul 14, 2023
8-K Report | Data Jun 8, 2023 Jun 7, 2023
10-Q Report | Data May 12, 2023 Mar 31, 2023
10-K Report | Data Mar 27, 2023 Dec 31, 2022
8-K Report | Data Mar 22, 2023 Mar 22, 2023
8-K/A Report | Data Mar 13, 2023 Mar 10, 2023
8-K Report | Data Mar 13, 2023 Mar 10, 2023
8-K Report | Data Jan 18, 2023 Jan 12, 2023
8-K Report | Data Dec 16, 2022 Dec 16, 2022
8-K Report | Data Dec 14, 2022 Dec 8, 2022
10-Q Report | Data Nov 9, 2022 Sep 30, 2022
10-Q Report | Data Aug 12, 2022 Jun 30, 2022
8-K Report | Data Jun 9, 2022 Jun 8, 2022
10-Q Report | Data May 13, 2022 Mar 31, 2022
10-K Report | Data Mar 28, 2022 Dec 31, 2021
SC 13G/A Report Mar 2, 2022
SC 13G/A Report AMENDMENT TO SC 13G Feb 11, 2022
SC 13G Report Feb 9, 2022
8-K Report Jan 19, 2022 Jan 19, 2022
8-K Report Jan 12, 2022 Jan 12, 2022
8-K Report Jan 3, 2022 Jan 3, 2022
SC 13G Report SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP Dec 28, 2021
8-K Report Dec 20, 2021 Dec 20, 2021